Cindy Varga
Advanced in Relapsed Refractory Multiple Myeloma (RRMM)

Dr. Cindy Varga

Hematology | Internal Medicine
Atrium Health
Atrium Health Levine Cancer Institute (Hematology)
1021 Morehead Medical Drive, Building 2, Suite 60201, 
Charlotte, NC 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Advanced in Relapsed Refractory Multiple Myeloma (RRMM)
Atrium Health
Atrium Health Levine Cancer Institute (Hematology)
1021 Morehead Medical Drive, Building 2, Suite 60201, 
Charlotte, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Cindy Varga is a Hematologist and an Internal Medicine provider in Charlotte, North Carolina. Dr. Varga is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Primary Amyloidosis, Multiple Myeloma, Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Varga is currently accepting new patients.

Her clinical research consists of co-authoring 54 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Université De Montréal
Residency
McGill University
Specialties
Hematology
Internal Medicine
Licenses
Internal Medicine in NC
Board Certifications
American Board Of Internal Med, Hematology, 2019
Fellowships
Dana-Farber Cancer Institute
Hospital Affiliations
Atrium Health Cleveland
Carolinas Medical Center/behav Health
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Atrium Health Levine Cancer Institute (Hematology)
1021 Morehead Medical Drive, Building 2, Suite 60201, Charlotte, NC 28204
Call: 980-442-4363

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Enrollment Status: Recruiting
Publish Date: November 13, 2025
Intervention Type: Other, Biological, Drug
Study Drugs: Daratumumab, Dexamethasone, Lenalidomide
Study Phase: Phase 3
Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment (Which May Include High Dose Melphalan and Autologous Stem Cell Transplantation (HDM/SCT)) in Patients With AL Amyloidosis: Feasibility and Prognostic Significance
Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment (Which May Include High Dose Melphalan and Autologous Stem Cell Transplantation (HDM/SCT)) in Patients With AL Amyloidosis: Feasibility and Prognostic Significance
Enrollment Status: Completed
Publish Date: September 10, 2021
Intervention Type: Other
A Phase I Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis
A Phase I Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis
Enrollment Status: Terminated
Publish Date: August 21, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1 Study of ACTR087, an Autologous T Cell Product, in Combination With SEA-BCMA, a Monoclonal Antibody, in Subjects With Relapsed or Refractory Multiple Myeloma
A Phase 1 Study of ACTR087, an Autologous T Cell Product, in Combination With SEA-BCMA, a Monoclonal Antibody, in Subjects With Relapsed or Refractory Multiple Myeloma
Enrollment Status: Terminated
Publish Date: March 30, 2020
Intervention Type: Biological
Study Phase: Phase 1
View 3 Less Clinical Trials

54 Total Publications

Screening for Systemic Light-Chain Amyloidosis in Patients Over 60 with λ Monoclonal Gammopathies.
Screening for Systemic Light-Chain Amyloidosis in Patients Over 60 with λ Monoclonal Gammopathies.
Journal: Journal of clinical medicine
Published: May 14, 2025
View All 54 Publications
Similar Doctors
Peter Voorhees
Elite in Relapsed Refractory Multiple Myeloma (RRMM)
Dr. Peter Voorhees
Hematology | Oncology
Elite in Relapsed Refractory Multiple Myeloma (RRMM)
Dr. Peter Voorhees
Hematology | Oncology

Atrium Health Levine Cancer Institute (Hematology)

1021 Morehead Medical Drive, Building 2, Suite 60201, 
Charlotte, NC 
 (0.1 miles away)
980-442-4363
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Peter Voorhees is a Hematologist and an Oncologist in Charlotte, North Carolina. Dr. Voorhees is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Voorhees is currently accepting new patients.

Raymond Thertulien
Advanced in Relapsed Refractory Multiple Myeloma (RRMM)
Dr. Raymond Thertulien
Hematology
Advanced in Relapsed Refractory Multiple Myeloma (RRMM)
Dr. Raymond Thertulien
Hematology

Novant Health Cancer Institute - Elizabeth (Hematology)

125 Queens Road, Suite 610, 
Charlotte, NC 
 (0.9 miles away)
980-302-6600
Languages Spoken:
English, Creole, French, Spanish
See accepted insurances
Offers Telehealth

Raymond Thertulien is a Hematologist in Charlotte, North Carolina. Dr. Thertulien is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Chronic Lymphocytic Leukemia (CLL), Myeloproliferative Neoplasms (MPN), Relapsed Refractory Multiple Myeloma (RRMM), and Bone Marrow Aspiration.

Manisha Bhutani
Advanced in Relapsed Refractory Multiple Myeloma (RRMM)
Dr. Manisha Bhutani
Hematology | Oncology
Advanced in Relapsed Refractory Multiple Myeloma (RRMM)
Dr. Manisha Bhutani
Hematology | Oncology

Atrium Health Levine Cancer Institute (Hematology)

1021 Morehead Medical Drive, Building 2, Suite 60201, 
Charlotte, NC 
 (0.1 miles away)
980-442-4363
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Manisha Bhutani is a Hematologist and an Oncologist in Charlotte, North Carolina. Dr. Bhutani is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Schnitzler Syndrome, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Bhutani is currently accepting new patients.

VIEW MORE RELAPSED REFRACTORY MULTIPLE MYELOMA (RRMM) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Varga's expertise for a condition
ConditionClose
    • Distinguished
    • Cardiac Amyloidosis
      Dr. Varga is
      Distinguished
      . Learn about Cardiac Amyloidosis.
      See more Cardiac Amyloidosis experts
    • Monoclonal Gammopathy of Undetermined Significance (MGUS)
      Dr. Varga is
      Distinguished
      . Learn about Monoclonal Gammopathy of Undetermined Significance (MGUS).
      See more Monoclonal Gammopathy of Undetermined Significance (MGUS) experts
    • Multiple Myeloma
      Dr. Varga is
      Distinguished
      . Learn about Multiple Myeloma.
      See more Multiple Myeloma experts
    • Primary Amyloidosis
      Dr. Varga is
      Distinguished
      . Learn about Primary Amyloidosis.
      See more Primary Amyloidosis experts
    • Smoldering Multiple Myeloma
      Dr. Varga is
      Distinguished
      . Learn about Smoldering Multiple Myeloma.
      See more Smoldering Multiple Myeloma experts
    • Advanced
    • Bone Marrow Transplant
      Dr. Varga is
      Advanced
      . Learn about Bone Marrow Transplant.
      See more Bone Marrow Transplant experts
    • Cerebral Amyloid Angiopathy
      Dr. Varga is
      Advanced
      . Learn about Cerebral Amyloid Angiopathy.
      See more Cerebral Amyloid Angiopathy experts
    • Hereditary Cerebral Amyloid Angiopathy
      Dr. Varga is
      Advanced
      . Learn about Hereditary Cerebral Amyloid Angiopathy.
      See more Hereditary Cerebral Amyloid Angiopathy experts
    • Primary Localized Cutaneous Amyloidosis
      Dr. Varga is
      Advanced
      . Learn about Primary Localized Cutaneous Amyloidosis.
      See more Primary Localized Cutaneous Amyloidosis experts
    • Relapsed Refractory Multiple Myeloma (RRMM)
      Dr. Varga is
      Advanced
      . Learn about Relapsed Refractory Multiple Myeloma (RRMM).
      See more Relapsed Refractory Multiple Myeloma (RRMM) experts
    • Schnitzler Syndrome
      Dr. Varga is
      Advanced
      . Learn about Schnitzler Syndrome.
      See more Schnitzler Syndrome experts
    View All 7 Advanced Conditions
    • Experienced
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Varga is
      Experienced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Varga is
      Experienced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Varga is
      Experienced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Adult Immune Thrombocytopenia
      Dr. Varga is
      Experienced
      . Learn about Adult Immune Thrombocytopenia.
      See more Adult Immune Thrombocytopenia experts
    • Agranulocytosis
      Dr. Varga is
      Experienced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • Anemia
      Dr. Varga is
      Experienced
      . Learn about Anemia.
      See more Anemia experts
    View All 36 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.